Skip to main content

Table 2 Multivariable logistic regression analysis of breast cancer recurrence score (RS) ≥ 26

From: Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer

 

aOR

95% CI

P

Race

 Non-Hispanic White

Reference

  

 Hispanic White

0.93

0.86–1.00

0.04

 Black

1.19

1.12–1.26

 < 0.001

 Asian/Pacific Islander

1.03

0.95–1.13

0.45

Age

   

  < 50 years

Reference

  

 50 years or older

1.05

1.00–1.10

0.06

Facility

   

 Nonacademic

Reference

  

 Academic

0.98

0.94–1.01

0.19

Insurance

   

 None

Reference

  

 Private

1.02

0.88–1.19

0.82

 Government

0.97

0.84–1.14

0.74

Income

   

 Above median

Reference

  

 Below median

1.1

1.05–1.16

 < 0.001

Education

   

 Above median

Reference

  

 Below median

1.04

0.99–1.08

0.12

CDS

   

 0

Reference

  

 1

1.02

0.97–1.07

0.41

 2 + 

1.09

0.99–1.20

0.08

Year

   

 For every 1 year increase

0.98

0.97–0.99

 < 0.001

Histology

   

 Ductal or lobular carcinoma

Reference

  

 Other

0.74

0.70–0.78

 < 0.001

PR

   

 Positive

Reference

  

 Negative

6.59

6.31–6.89

 < 0.001

T staging

   

 1

Reference

  

 2

1.31

1.26–1.36

 < 0.001

 3

0.8

0.68–0.92

0.003

N staging

   

 0

Reference

  

 1a

0.8

0.76–0.85

 < 0.001

Grade

   

 1

Reference

  

 2

2.75

2.60–2.91

 < 0.001

 3

16.98

16.02–18.02

 < 0.001

 Other

21.15

13.28–33.64

 < 0.001

LVSI

   

 No

Reference

  

 Yes

1.22

1.16–1.28

 < 0.001

  1. aOR Adjusted odds ratio, CI Confidence interval, CDS Charlson-Deyo Comoribidty Score, PR progesterone receptor, LVSI Lymphovascular invasion